Safety Shot Inc (SHOT)
USD 0.48
(5.52%)
USD 0.48
(5.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -12.18 Million USD | -11.1% |
| 2022 | -15.29 Million USD | 33.84% |
| 2021 | -26.17 Million USD | -233.47% |
| 2020 | -6.01 Million USD | -440.94% |
| 2019 | -918.9 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -8.3 Million USD | 48.11% |
| 2024 Q1 | -15.06 Million USD | -178.34% |
| 2023 Q1 | -1.22 Million USD | 81.03% |
| 2023 Q3 | -7.15 Million USD | -2432.94% |
| 2023 FY | - USD | -12.92% |
| 2023 Q4 | -5.42 Million USD | 24.12% |
| 2023 Q2 | -282.4 Thousand USD | 76.97% |
| 2022 FY | - USD | 33.84% |
| 2022 Q4 | -6.46 Million USD | -267.98% |
| 2022 Q3 | -1.75 Million USD | -101.92% |
| 2022 Q2 | -870.33 Thousand USD | 52.47% |
| 2022 Q1 | -1.83 Million USD | 71.79% |
| 2021 Q3 | -3.57 Million USD | 1.61% |
| 2021 Q4 | -6.49 Million USD | -81.53% |
| 2021 FY | - USD | -233.47% |
| 2021 Q1 | -2.84 Million USD | 39.54% |
| 2021 Q2 | -3.63 Million USD | -27.97% |
| 2020 Q4 | -4.69 Million USD | -802.04% |
| 2020 Q2 | -350.43 Thousand USD | 20.85% |
| 2020 Q1 | -442.72 Thousand USD | 31.82% |
| 2020 FY | - USD | -440.94% |
| 2020 Q3 | -520.72 Thousand USD | -48.59% |
| 2019 Q1 | -73.54 Thousand USD | 0.0% |
| 2019 Q4 | -649.37 Thousand USD | -411.45% |
| 2019 Q3 | -126.96 Thousand USD | -83.94% |
| 2019 FY | - USD | 0.0% |
| 2019 Q2 | -69.02 Thousand USD | 6.14% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 103.952% |
| Embecta Corp. | 245.4 Million USD | 104.965% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 111.146% |
| Dynavax Technologies Corporation | 9.66 Million USD | 226.062% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 91.882% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 107.48% |
| PainReform Ltd. | -9.56 Million USD | -27.34% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 1130.895% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -218.615% |
| SCYNEXIS, Inc. | 73.47 Million USD | 116.583% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -418.296% |
| Cosmos Health Inc. | -17.06 Million USD | 28.582% |
| Journey Medical Corporation | 1.92 Million USD | 734.315% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -218.615% |
| Alpha Teknova, Inc. | -25.53 Million USD | 52.288% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 92.329% |
| Bright Green Corporation | - USD | Infinity% |
| Procaps Group, S.A. | 104.02 Million USD | 111.713% |
| Theratechnologies Inc. | -10.31 Million USD | -18.156% |
| Harrow Health, Inc. | 9.72 Million USD | 225.323% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -169.286% |
| Biofrontera Inc. | -18.45 Million USD | 33.966% |
| DURECT Corporation | -24.68 Million USD | 50.635% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 112.401% |
| Cronos Group Inc. | -72.14 Million USD | 83.111% |
| OptiNose, Inc. | -15.55 Million USD | 21.654% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 98.682% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 66.229% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 146.391% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 133.819% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -210.66% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -1614.171% |
| Radius Health, Inc. | 38.31 Million USD | 131.807% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -279.002% |
| ProPhase Labs, Inc. | -14.82 Million USD | 17.818% |
| Phibro Animal Health Corporation | 84.6 Million USD | 114.402% |
| Procaps Group S.A. | 104.02 Million USD | 111.713% |
| Alvotech | -484.86 Million USD | 97.487% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -45.044% |
| Viatris Inc. | 3.51 Billion USD | 100.347% |
| Rockwell Medical, Inc. | -4.69 Million USD | -159.591% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -1104.07% |
| SIGA Technologies, Inc. | 84.15 Million USD | 114.479% |
| Tilray Brands, Inc. | -72.84 Million USD | 83.272% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 1600.638% |
| Shineco, Inc. | -26.55 Million USD | 54.112% |
| PetIQ, Inc. | 81.48 Million USD | 114.954% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -236.828% |
| Incannex Healthcare Limited | -18.5 Million USD | 34.148% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 102.928% |
| Alimera Sciences, Inc. | 7.27 Million USD | 267.471% |
| Silver Spike Investment Corp. | 7.34 Million USD | 266.008% |
| Assertio Holdings, Inc. | -222.44 Million USD | 94.522% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -205.343% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -189.306% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 27.486% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 39.168% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 91.829% |
| Hempacco Co., Inc. | -12.77 Million USD | 4.604% |
| Talphera, Inc. | -9.84 Million USD | -23.808% |
| Alvotech | -484.86 Million USD | 97.487% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 115.722% |
| Lantheus Holdings, Inc. | 491 Million USD | 102.482% |
| Currenc Group, Inc. | -1.9 Million USD | -541.132% |
| Kamada Ltd. | 21.53 Million USD | 156.586% |
| Indivior PLC | 66 Million USD | 118.462% |
| Evoke Pharma, Inc. | -7.29 Million USD | -67.097% |
| Flora Growth Corp. | -45.87 Million USD | 73.435% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 39.168% |
| Evolus, Inc. | -41.81 Million USD | 70.856% |
| HUTCHMED (China) Limited | 25.52 Million USD | 147.733% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 105.046% |
| Akanda Corp. | -27.73 Million USD | 56.067% |